Company intelligence / Profile preview

Therawis

Ownership: Private
Development stage: Other

Overview

Therawis is a privately held group of companies based in Munich, Germany, specializing in life science research and precision medicine with a strong focus on oncology. The group provides clinical and medical affairs support for therapeutics and diagnostics, particularly IVD devices. They emphasize combining innovative diagnostics with effective therapeutics using a "theranostic approach." The team has significant expertise in life cycle management of diagnostic devices[1][2][3][7].

Therapeutic areas: ImmunologyOncology
Modalities: Diagnostic substances
Industry: Contract Research Organization

Partnerships

CliniciansAcademic institutions

Beyond the preview

Go deeper on Therawis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therawis.

Explore the full profile